The U.S. Food and Drug Administration on Wednesday warned about the risk of a rare but serious allergic reaction with the use ...
The U.S. Food and Drug Administration on Wednesday warned about the risk of a rare but serious allergic reaction with the use ...
HealthDay on MSN1d
Multiple Sclerosis May Worsen With Menopause TransitionThe menopausal transition may represent an inflection point for worsening of multiple sclerosis (MS) in women, accordi ...
People with multiple sclerosis (MS) face a significantly higher risk of perinatal mental illness compared to those with other ...
MS patients who achieve long-term stable disease on disease-modifying therapy may want to stop their medication for varying ...
GlobalData on MSN2d
FDA adds boxed warning to multiple sclerosis drugs after anaphylaxis casesTeva Pharmaceutical’s Copaxone was approved by the FDA in 1996 to treat relapsing forms of MS, an autoimmune disorder that ...
The FDA issued a boxed warning for anaphylaxis risk linked to Glatiramer acetate and Glatopa, used in MS treatment.
After years of legal wrangling surrounding Teva’s Copaxone, the latest hit to the lucrative multiple sclerosis drug comes in ...
Researchers at the University of Colorado Anschutz Medical Campus have found a promising drug candidate that could help ...
Researchers at the University of Colorado Anschutz Medical Campus have identified LL-341070, a promising drug candidate that ...
A new study reveals that people with multiple sclerosis (MS) experience significantly higher rates of mental illness during ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback